Neutrogena Stubborn Body Acne Treatment

Description

Neutrogena® is a dermatologist-recommended brand offering a new treatment spray specifically designed for stubborn body acne. This formulation contains 2% salicylic acid, an effective acne treatment that clears existing acne and helps prevent future breakouts. The product is fragrance-free, making it suitable for sensitive skin. It is ideal for application on the back and chest, providing targeted treatment for these areas. Each container holds 5.5 fluid ounces (162 mL) of the solution.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears existing acne lesions and helps prevent the formation of new acne. This formulation is particularly suitable for application on the back and chest.

Limitations of Use: The teratogenic and nonteratogenic effects of this drug have not been specified. Therefore, healthcare professionals should exercise caution and consider individual patient circumstances when prescribing this medication.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This can be done one to three times daily, depending on the patient's needs and the physician's guidance.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once a day or every other day to alleviate these symptoms.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Avoid contact with the eyes; if contact occurs, flush the eyes immediately with water. Additionally, the use of this product concurrently with other topical acne medications may increase the risk of skin irritation and dryness. Therefore, it is recommended to use only one topical acne medication at a time to minimize the potential for irritation.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

Healthcare professionals should advise patients to avoid contact with the eyes. In the event of accidental contact, it is imperative to immediately flush the eyes with water to mitigate potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. It is recommended that patients use only one topical acne medication at a time to minimize the risk of adverse skin reactions.

This product should be stored out of reach of children. In the case of ingestion, it is crucial to seek medical assistance or contact a Poison Control Center without delay to ensure appropriate management.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire or flame.

During use, it is important to avoid contact with the eyes. In the event of contact, patients should immediately flush the eyes with water. Skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. To minimize the risk of irritation, it is advised that only one topical acne medication be used at a time.

This product should be kept out of reach of children. In the case of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Stubborn Body Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Neutrogena Stubborn Body Acne Treatment in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this treatment to geriatric patients, as the absence of data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid during pregnancy is generally contraindicated due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid in pregnant individuals. Therefore, pregnant women should consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise clinical judgment when prescribing to patients with renal impairment, as specific recommendations are not provided in the current labeling.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be cautioned to avoid contact with their eyes. In the event of accidental contact, they should immediately flush their eyes with water to minimize irritation.

It is important to inform patients that using this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. If patients experience irritation, they should be advised to limit their use to one topical acne medication at a time to reduce the risk of adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its efficacy and integrity. No special handling requirements are necessary beyond standard storage practices.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or as directed by a healthcare professional.

Clinicians should counsel patients to avoid contact with the eyes, flushing with water immediately if contact occurs. It is important to note that using this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness; therefore, only one topical acne medication should be used at a time if irritation develops. Additionally, due to the presence of an alpha hydroxy acid (AHA), patients are advised that their skin may become more sensitive to sunlight, increasing the risk of sunburn. Patients should be instructed to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week after discontinuation.

Drug Information (PDF)

This file contains official product information for Neutrogena Stubborn Body Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)